Biocon Limited has informed the Exchange regarding a press release dated April 15, 2025, titled "Biocon Biologics Secures Market Entry Date for Yesafili , an Interchangeable Biosimilar to Eylea?, in the U.S.".
Biocon Limited has informed the Exchange regarding a press release dated April 15, 2025, titled "Biocon Biologics Secures Market Entry Date for Yesafili , an Interchangeable Biosimilar to Eylea?, in the U.S.".